Shanmuga Hospital List: Shares of Shanmuga Hospital started a flat market on Friday, 21 February, as they were listed 54 APIS on BSE SME, similar to IPO value. Post listing, tumblled in stock 51.30 AP, 5% less than IPO price.
The IPO was open to bid from 13 February to 17 February and was 2.51 times higher than the bid. The retail part was booked 4.41 times, while the non-institutional investor (NII) part was subscribed 0.6 times.
20.62 crore IPO was completely a new issue of 38.18 lakh shares. IPO was priced 54 per share. The company plans to use additional medical equipment and funds raised to purchase general corporate purposes.
About Shanmug Hospital
Shanmuga is located in Hospital, Salem, Tamil Nadu, a multi -level feature with 151 beds, offering advanced health services services. Recognized by NABH and NABL, it ensures high quality care in prevention, treatment and rehabilitation. The hospital has special units including Oncology, HDU, ED, CCU, ICU, NICU, labor room, endoscopy room, neurosurgery and cardiac unit.
Its clinical center is equipped with state-of-the-art imaging and laboratory technologies such as X-rays, ultrasound, CT scans, MRI and modular operation theaters. Shanmuga Hospital provides extensive inconsistent and outpatient care in a range of specialties, meeting the needs of diverse health services of the hospital area.
The company is also associated with government agencies, companies and organizations to provide health care facilities to its employees and their dependents. Additionally, it is insured and imperialist with TPA providers.
FY 2024, Financial 2023, and Financial 2022, the company generated total income 43.39 crores, 39.50 crores, and 41.47 crore, respectively, Ebitda (Operations Benefits) 8.95 crores, 7.44 crores, and 9.13 crores, respectively, and tax after tax 5.26 crores, 4.76 crores, and 6.72 crores respectively.
It has reported a return to the total assets of 30.71%, 40.28%, and FY 2024, FY 2023, FY 2023 and FY 2022, respectively, according to the company’s DRHP report.
Rejuvenation, The views and recommendations given in this article are of individual analysts. They do not represent the ideas of mint. We recommend investors to investigate with certified experts before taking any investment decisions.
